Article

Dr. Marcus Wilson Discusses How Comparative Effectiveness Research is Used in the Managed Care Setting

Marcus D. Wilson, PharmD, President, HealthCore, states that there is variability within and between different organizations that utilize comparative effectiveness research.

Marcus D. Wilson, PharmD, President, HealthCore, states that there is variability within and between different organizations that utilize comparative effectiveness research.

Comparative effectiveness research is used to better understand populations impacted by decisions, and is used to customize policy for specific populations.

Related Videos
Jonathan Eisengart, MD
Chelsee Jensen, PharmD, BCPS.
Jonathan Eisengart, MD
Sarah Anderson, oncology strategy lead director, Novotech
Jonathan Eisengart
Dawn Klemow, MD, assistant clinical professor, The University of Texas Southwestern Medical Center
Jonathan Eisengart
Tiago Biachi, MD, PhD
Related Content
Travis Brewer, Texas Oncology
January 30th 2025

Balancing Cost and Quality in Oncology: A Value-Based Care Perspective

Skylar Jeremias Travis Broome, MPH, MBA
Travis Brewer, vice president of payer and public health strategy/relations at Texas Oncology, shared that value-based oncology care can achieve both cost efficiency and high-quality outcomes through integrated multidisciplinary teams, flexible payment models, and targeted treatment approaches.
managed care cast logo
January 28th 2025

The Evolving Annual Wellness Visit

Laura Joszt, MA Christopher Wheelock, MD
The annual wellness visit is beneficial for patients, providers, and payers with an emphasis on preventive care for early intervention.
Kirollos Hanna, PharmD
January 29th 2025

Embracing EOM, Enhancing Collaboration and Cost Management: Dr Kirollos Hanna

Kyle Munz Kirollos Hanna, PharmD
The design of the Enhancing Oncology Model (EOM) was a perfect fit for Minnesota Oncology.
managed care cast logo
January 23rd 2025

Unlocking Access: Exploring Mental Health Care Among Medicaid Managed Care Enrollees

Brooke McCormick Ju-Chen Hu, PhD
On this episode of Managed Care Cast, we speak with the author of a study published in the January 2025 issue of The American Journal of Managed Care® to examine the association between quantitative network adequacy standards and mental health care access among adult Medicaid enrollees.
FDA approval | image credit: Aquir - stock.adobe.com
January 28th 2025

FDA Expands Semaglutide Use for CV, Kidney Risks in T2D, CKD

Kyle Munz
The latest semaglutide (Ozempic; Novo Nordisk) approval is set to tackle a major need for patients with both type 2 diabetes (T2D) and chronic kidney disease (CKD), addressing their cardiovascular (CV) and kidney disease risks.
The investigators believe their decades-spanning analysis underscores the need to address access barriers to anti-obesity therapeutics | image credit: TAW4 - stock.adobe.com
January 28th 2025

"Alarming Rise" of Global MASH-Related Primary Liver Cancer Incidence Since 2000

Kyle Munz
The investigators believe their decades-spanning analysis underscores the need to address access barriers to anti-obesity therapeutics.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo